Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-5C (RAB5C) is a small GTPase of the Rab family within the Ras superfamily, acting as a key regulator of intracellular membrane trafficking, particularly endocytosis and vesicle fusion[1][7]. RAB5C cycles between inactive (GDP-bound) and active (GTP-bound) forms, coordinating the docking and/or fusion of vesicles to their correct membrane compartments[1][2][7]. It plays a master role in the endocytic pathway, including the uptake of extracellular materials, recycling or degradation of membrane proteins and signal transduction, notably through growth factor receptors such as EGF and VEGF[2]. RAB5C is expressed broadly in human tissues including the nervous system, vasculature, and various organ systems[8]. Pathogenic variants in RAB5C are associated with neurodevelopmental disorders, most notably macrocephaly, developmental delay, and epilepsy, and have also been implicated in cancer cell proliferation and response to viral infection[1][2][6][9].
No known approved drugs with direct mechanism of action; implicated in disease modulation through regulation of endocytosis, trafficking, and signal transduction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-5C (RAB5C).